These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 15761234
1. The role of insulin-like growth factor I monitoring in growth hormone-treated children. Park P, Cohen P. Horm Res; 2004; 62 Suppl 1():59-65. PubMed ID: 15761234 [Abstract] [Full Text] [Related]
2. Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS). Park P, Cohen P. Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S13-20. PubMed ID: 16039893 [Abstract] [Full Text] [Related]
3. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age. Cutfield WS, Lundgren F. Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504 [Abstract] [Full Text] [Related]
4. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA. Horm Res; 2005 Jan; 63(1):40-7. PubMed ID: 15627781 [Abstract] [Full Text] [Related]
5. Clinical and humanistic aspects of growth hormone deficiency and growth-related disorders. Rogol AD. Am J Manag Care; 2011 Dec; 17 Suppl 18():eS4-10. PubMed ID: 22590765 [Abstract] [Full Text] [Related]
6. [Is there a relationship between the growth hormone dose and tumoral or cardiovascular complications?]. Le Bouc Y, Brioude F. Bull Acad Natl Med; 2012 Jan; 196(1):127-35; discussion 135-7. PubMed ID: 23259340 [Abstract] [Full Text] [Related]
11. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. Festen DA, Visser TJ, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC. Clin Endocrinol (Oxf); 2007 Sep; 67(3):449-56. PubMed ID: 17716335 [Abstract] [Full Text] [Related]
12. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor. Meyer S, Ipek M, Keth A, Minnemann T, von Mach MA, Weise A, Ittner JR, Nawroth PP, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Kann PH, German KIMS Board, German KIMS Pharmacogenetics Study Group. Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934 [Abstract] [Full Text] [Related]
13. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Högler W, Briody J, Moore B, Lu PW, Cowell CT. Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578 [Abstract] [Full Text] [Related]
14. Growth and growth hormone treatment in short stature children born small for gestational age. Labarta JI, Ruiz JA, Molina I, De Arriba A, Mayayo E, Longás AF. Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234 [Abstract] [Full Text] [Related]
15. Role of insulin-like growth factor monitoring in optimizing growth hormone therapy. Wetterau L, Cohen P. J Pediatr Endocrinol Metab; 2000 Feb; 13 Suppl 6():1371-6. PubMed ID: 11202212 [Abstract] [Full Text] [Related]
16. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children. Ali A, Hashim R, Khan FA, Sattar A, Ijaz A, Manzoor SM, Younas M. J Ayub Med Coll Abbottabad; 2009 Feb; 21(3):40-5. PubMed ID: 20929010 [Abstract] [Full Text] [Related]
17. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term. de Zegher F, Hokken-Koelega A. Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349 [Abstract] [Full Text] [Related]
18. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS. Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221 [Abstract] [Full Text] [Related]
19. Growth hormone treatment for short stature in children born small for gestational age. Jung H, Rosilio M, Blum WF, Drop SL. Adv Ther; 2008 Oct; 25(10):951-78. PubMed ID: 18836868 [Abstract] [Full Text] [Related]
20. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM. Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949 [Abstract] [Full Text] [Related] Page: [Next] [New Search]